|
Jul 28
|
BofA Reiterates a Sell Rating on Amgen (AMGN)
|
|
Jul 28
|
BMO Cuts Amgen (AMGN) Price Target After Mixed MariTide Data at ADA Conference
|
|
Jul 27
|
Dogs of the Dow: Why Amgen’s (AMGN) Dividend Power Makes it a Standout Pick
|
|
Jul 27
|
Is Amgen Inc. (NASDAQ:AMGN) Trading At A 50% Discount?
|
|
Jul 25
|
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
|
|
Jul 24
|
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
|
|
Jul 24
|
Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities
|
|
Jul 24
|
Looking Beyond Yield for the Safest Dividend Payers
|
|
Jul 24
|
2 Reasons to Like AMGN and 1 to Stay Skeptical
|
|
Jul 23
|
Rheumatoid Arthritis Therapeutics Market Forecast Report 2025-2034 | Rising Preference for Combination Therapies, and Entry of Generic Drugs Supports Expansion
|
|
Jul 23
|
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
|
|
Jul 23
|
Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns
|
|
Jul 23
|
Do You Believe in the Growth Potential of Amgen (AMGN)?
|
|
Jul 23
|
Calciphylaxis Market Forecast Report 2025-2034 | Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) Fueling Demand and Growth
|
|
Jul 22
|
Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
|
|
Jul 21
|
EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships
|
|
Jul 21
|
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
|
|
Jul 19
|
Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025
|
|
Jul 18
|
Amgen (AMGN) Declines More Than Market: Some Information for Investors
|
|
Jul 18
|
HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating
|